Sun Pharma aims to protect supply chain, preserve cash amid COVID challenges
Shanghvi said that the company is also looking at supply chain protection, ensuring optimum utilisation of its factories and working closely with vendors to ensure continuity of supply while at the same time continuing focus on improving productivity throughout.
New Delhi: Drug major Sun Pharma aims to gain market share in all the verticals it is present in amid challenges posed by the coronavirus pandemic, as per a top company official. "Our endeavour will be to gain market share in each of our business by doing better. Despite the near-term uncertainties related to COVID-19, we hope to be able to do better consistently," Sun Pharmaceutical Industries MD Dilip Shanghvi said in an analyst call.